These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6171 related articles for article (PubMed ID: 3266207)

  • 21. Syngeneic anti-idiotypes against monoclonal anti-HLA-DR antibodies: characterization of recurrent idiotopes.
    Piatier-Tonneau D; Boyer B; Debre P; Charron DJ
    J Immunol; 1983 Sep; 131(3):1339-43. PubMed ID: 6193186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping the idiotopes of a monoclonal anti-myoglobin antibody with syngeneic monoclonal anti-idiotypic antibodies: detection of a common idiotope.
    Streicher HZ; Cuttitta F; Buckenmeyer GK; Kawamura H; Minna J; Berzofsky JA
    J Immunol; 1986 Feb; 136(3):1007-14. PubMed ID: 3484497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation by antiidiotypic monoclonal antibodies of immune lysis mediated by anti-HLA monoclonal antibodies.
    Ono R; Sakaguchi K; Ferrone S
    J Immunol; 1989 Sep; 143(6):1921-9. PubMed ID: 2528584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Idiotypic analysis of anti-I-Ak monoclonal antibodies. I. Production and characterization of syngeneic anti-idiotypic mAb against an anti-I-Ak mAb.
    Phillips ML; Harris JF; Delovitch TL
    J Immunol; 1984 Nov; 133(5):2587-94. PubMed ID: 6434633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Idiotypic analysis of anti-I-Ak monoclonal antibodies. II. Detection of shared idiotopes on syngeneic BALB/c and allogeneic A.TH-derived anti-I-Ak mAb by BALB/c-derived anti-I-Ak anti-idiotypic mAb.
    Devaux CA; Phillips ML; Delovitch TL
    J Immunol; 1984 Nov; 133(5):2595-602. PubMed ID: 6207236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diversity of anti-HLA-DR antibodies elicited by distinct anti-idiotypic monoclonal antibodies recognizing idiotopes co-expressed by the immunizing monoclonal antibody.
    Mariani SM; Armandola EA; Ferrone S
    Immunology; 1992 Dec; 77(4):597-603. PubMed ID: 1283602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three new cross-reacting idiotopes as markers for the products of two distinct human VH3 genes expressed in the early repertoire.
    Suleyman S; Thompson KM; Førre O; Sioud M; Randen I; Mageed RA; Natvig JB
    Scand J Immunol; 1994 Dec; 40(6):681-90. PubMed ID: 7527936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulatory role of a monomorphic determinant of HLA Class I antigens in T cell proliferation.
    Turco MC; De Felice M; Corbo L; Morrone G; Mertelsmann R; Ferrone S; Venuta S
    J Immunol; 1985 Oct; 135(4):2268-73. PubMed ID: 2411790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production, binding characteristics, and immunogenicity of heterologous anti-idiotypic antibody to herpes simplex virus glycoprotein C.
    Lathey JL; Courtney RJ; Rouse BT
    Viral Immunol; 1987; 1(1):13-23. PubMed ID: 3509672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
    Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
    J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of anti-class I cytotoxicity by anti-class II monoclonal antibodies (MoAb). I. Blocking of bulk non-DR and non-DQ-directed cytotoxic T cells by MoAb against DR, DQ, and DP.
    Strassmann G; Ress S; Anichini A; Bach FH
    Hum Immunol; 1985 Jun; 13(2):125-37. PubMed ID: 3874193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
    Pesando JM; Graf L
    J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of antigen-specific immune response with use of anti-idiotypic monoclonal antibodies to anti-carcinoembryonic antigen antibodies.
    Tsujisaki M; Imai K; Tokuchi S; Hanzawa Y; Ishida T; Kitagawa H; Hinoda Y; Yachi A
    Cancer Res; 1991 May; 51(10):2599-604. PubMed ID: 2021940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The immune response against anti-idiotope antibodies. I. Induction of idiotope-bearing antibodies and analysis of the idiotope repertoire.
    Takemori T; Tesch H; Reth M; Rajewsky K
    Eur J Immunol; 1982 Dec; 12(12):1040-6. PubMed ID: 6984391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of HLA-DR, DQ, and DP antigens in primary and metastatic melanoma.
    van Vreeswijk H; Ruiter DJ; Bröcker EB; Welvaart K; Ferrone S
    J Invest Dermatol; 1988 May; 90(5):755-60. PubMed ID: 3283252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recognition of several idiotopes on a monoclonal anti-hepatitis B virus surface antigen using monoclonal anti-idiotypic antibodies.
    Thanavala YM; Moore MJ; Tedder R; Hay FC; Roitt IM
    Immunology; 1988 Apr; 63(4):575-7. PubMed ID: 3259202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human high molecular weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody MK2-23. Characterization of the immunogenicity in syngeneic hosts.
    Chen ZJ; Yang H; Ferrone S
    J Immunol; 1991 Aug; 147(3):1082-90. PubMed ID: 1861071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of anti HMW.MAA antibodies in sera of melanoma patients using antiidiotypic monoclonal antibodies].
    Nakamura T; Kageshita T; Arao T; Yamazaki N; Ishihara K
    Nihon Hifuka Gakkai Zasshi; 1990 Oct; 100(11):1121-6. PubMed ID: 2273574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibodies that distinguish between class II antigens (HLA-DP, DQ, and DR) in 14 haplotypes.
    Robbins PA; Evans EL; Ding AH; Warner NL; Brodsky FM
    Hum Immunol; 1987 Apr; 18(4):301-13. PubMed ID: 3494718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 309.